Yanling Wu

Key Laboratory Of Medical Molecular Virology And Shanghai Institute Of Infectious Disease And Biosecurity
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Novel Selenium-Containing Small Molecule PD-L1 Inhibitors: Design, Synthesis, and Evaluation of the Antitumor Activity.

Novel Selenium-Containing Small Molecule PD-L1 Inhibitors: Design, Synthesis, and Evaluation of the Antitumor Activity.

Journal: Journal of medicinal chemistry

Published: July 03, 2026

Screening of Monoclonal Antibodies from Integrated Phage and Mammalian Cell Display Libraries.

Screening of Monoclonal Antibodies from Integrated Phage and Mammalian Cell Display Libraries.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: May 13, 2026

Respiratory Syncytial Virus (RSV) Prophylaxis: Clesrovimab and Beyond.

Respiratory Syncytial Virus (RSV) Prophylaxis: Clesrovimab and Beyond.

Journal: Journal of medicinal chemistry

Published: January 08, 2026

Development of human single-domain antibodies against influenza based on NA-targeting IgG.

Development of human single-domain antibodies against influenza based on NA-targeting IgG.

Journal: Biochemical and biophysical research communications

Published: November 25, 2025

Modulating Subcellular Localization to Preserve the Stability and Functionality of Intracellular Nanobodies.

Modulating Subcellular Localization to Preserve the Stability and Functionality of Intracellular Nanobodies.

Journal: Antibodies (Basel, Switzerland)

Published: September 05, 2025

NIR Ratiometric Fluorescent Antibody-Drug Conjugate for Metastatic Ovarian Cancer Theranostics and Treatment Response Monitoring.

NIR Ratiometric Fluorescent Antibody-Drug Conjugate for Metastatic Ovarian Cancer Theranostics and Treatment Response Monitoring.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 28, 2025

Advancing bidirectional hydrogen spillover in heterostructure catalysts for electrocatalytic antimony removal and recovery from wastewater.

Advancing bidirectional hydrogen spillover in heterostructure catalysts for electrocatalytic antimony removal and recovery from wastewater.

Journal: Journal of hazardous materials

Published: August 19, 2025

Engineering a novel light-chain single-domain antibody to enable IgG-format bispecific antibody design.

Engineering a novel light-chain single-domain antibody to enable IgG-format bispecific antibody design.

Journal: Antibody therapeutics

Published: July 17, 2025

Innovations in cancer immunotherapy with PD-1 antibody-drug conjugates and their antitumor mechanisms.

Innovations in cancer immunotherapy with PD-1 antibody-drug conjugates and their antitumor mechanisms.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 11, 2025

An IL-15-modified NKp30×HER2 trispecific NK cell engager enhances NK cell activation and tumor cell killing.

An IL-15-modified NKp30×HER2 trispecific NK cell engager enhances NK cell activation and tumor cell killing.

Journal: Journal of leukocyte biology

Published: June 05, 2025

Novel PD-L1 Small-Molecule Inhibitors Advancing Cancer Immunotherapy.

Novel PD-L1 Small-Molecule Inhibitors Advancing Cancer Immunotherapy.

Journal: Anti-cancer agents in medicinal chemistry

Published: March 15, 2025

Nearly complete redirection of insertion-type indel into recombination enhances knock-in and facilitates endogenous biomolecular condensate analysis.

Nearly complete redirection of insertion-type indel into recombination enhances knock-in and facilitates endogenous biomolecular condensate analysis.

Journal: Cell research

Published: February 13, 2025

Showing 1-12 of 69

Last Updated: 09/26/2026